Lv3
278 积分 2022-05-24 加入
The activated transforming growth factor‐beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
1天前
已完结
Targeting TGF-β: a promising strategy for cancer therapy
1天前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
1天前
已关闭
A Multicenter Randomized, Controlled Clinical Trial of Adjuvant Sintilimab for Esophageal Squamous Cell Carcinoma
28天前
已完结
Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis
28天前
已完结
Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
1个月前
已完结
Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial
1个月前
已完结
Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself
1个月前
已完结
Which sarcoma requires PD1/PDL1 inhibitors, and what should be the best scheme? Present status and next steps
1个月前
已关闭
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
